Prescribers cite ways to alleviate systemic threats to their ability to serve.
Physician burnout remains a persistent obstacle to providing quality healthcare–and an unspoken factor in prescriber dialogues across pharma interactions. It’s an underlying driver and threat to physician retention,1 staffing shortages, medical errors,2 and healthcare professional (HCP) mental health.
When prescribers are asked how pharma companies can help, doctors have a lot to say–with often incisive remarks.
A 2023 InCrowd report3 finds that US physician burnout declined slightly in 2023, with 64% percent of healthcare professionals (HCPs) saying they are frustrated by the pressure put on them today–down from 70% in 2022, yet more than the 47% found in 2021. Data were fielded in January 2024 and corroborate other recent reports.
Nearly one in four HCPs in the US now say they feel the impact of professional burnout on their mental health (26%), or that they are burned out professionally (23%). “We get treated like a drive-through restaurant. They want to order something, and leave,” said a neurologist.
More than half (52%) say that burnout frequently impacts doctors’ ability to provide high-quality clinical care to their patients. One in four HCPs feel their clinical practice does not effectively address staff burnout. “The quality of care is not as important as the quantity of care,” said a PCP.
One quarter of doctors in 2023 say they are considering leaving their clinical profession. Only 27% today would encourage a family member to pursue their career.
Unlike recent studies, only 28% of HCPs in InCrowd’s report4 say that AI can significantly alleviate burnout through administrative automation. Even fewer HCPs see significant benefit from any of five other AI-enabled technologies: virtual health assistants (13%), remote patient monitoring (10%), diagnosis assistance (9%), personalized treatment plans (8%), and healthcare chatbots (6%).
Three-quarters of female physicians are frustrated by the pressure put on HCPs today, compared to 58% of male physicians–with fewer female doctors (27%) feeling appreciated, compared to 35% of male doctors. Younger doctors under age 50 also are more frustrated (66% vs 62%) and fewer feel appreciated (29% vs. 35%).
Two-thirds of prescribers agree that pharmas can help to alleviate burnout, offering specifics across five categories:
HCPs are using their collective voice to share ideas on ways to mitigate burnout. When pharma teams act to lighten the load on prescribers, they show that they value the HCPs whose life-saving capabilities ultimately take care of us all.
Daniel S. Fitzgerald is CEO and President of Apollo Intelligence
Cell and Gene Therapy Check-in 2024
January 18th 2024Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.
Delivery and Disruption: Navigating a Changing Care Terrain
September 16th 2024The diversification of site-of-care delivery models is accelerating rapidly, creating new go-to-market implications for drug manufacturers—but also new opportunities to drive more fundamental innovation in engagement and access strategies.